2024. Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-year Results From Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s435. DOI:https://doi.org/10.25251/skin.8.supp.435.